Hip Replacement Implants Market Size, Share & Trends Analysis Report By Product (Total Hip, Partial Femoral Head), By Material (Metal-on-Polyethylene, Ceramic-on-Polyethylene), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The globalhip replacement implants market sizewas estimated atUSD 5.4 billion in 2022,预计年复合增长的恶性肿瘤h rate (CAGR) of 6.2% from 2023 to 2030. The rising incidence of obesity, hip injuries, and osteoarthritis drive the market growth. For instance, according to a World Health Organization (WHO) study in 2021, there were 528 million osteoarthritis patients worldwide. WHO estimates that by the year 2050, there will be 130 million osteoarthritis patients worldwide and 40 million people disabled due to the disease. Since cases of osteoarthritis have increased, there is likely to be an increased demand for hip replacement surgeries and the need for hip replacement implants, which will contribute to the market growth further.

Other factors, such as a growing geriatric population and an increasing prevalence of hip fractures, are expected to drive the hip replacement implants market’s growth over the forecast period. For instance, according to a report from the UN's Department of Economic and Social Affairs titled "World Population Ageing 2020 Highlights," in 2020, there were 727 million people worldwide who were 65 or older. That number is expected to rise to over 1.5 billion in 2050. Additionally, the number of people over 65 is expected to rise globally from 9.3% in 2020 to around 16.0% in 2050. The growing incidence of osteoarthritis in elderly people is also anticipated to positively impact the growth of the market.

Growing awareness and increasing accessibility of hip surgical solutions are boosting the procedural volume. The average age of Americans undergoing hip replacements is also increasing, thereby, recording a surge in procedural volumes. As per a national study by the American Academy of Orthopedic Surgeons, the average age of patients undergoing hip replacements has decreased to just under 65, owing to new joint replacement techniques & technologies such as direct anterior approach for hip replacement, image-guided surgery, and cement-less technology for hip replacement. With an increasing prevalence of diabetes and obesity in the U.S., there is also an increased need for surgery at younger ages. Furthermore, the increased number of young people suffering from degenerative diseases will continue to increase the demand for hip replacement implants over the forecast period.

Favorable reimbursement policies also contribute to market growth. For example, as per the Patient Protection and Affordable Care Act (PPACA), the range of coverage provided by insurance companies inorthopedic devicesis growing, thus enabling more patient access. In recent years, both the public sector (such as the CMS) and commercial insurance providers have adequately covered orthotics and prosthetics.

COVID-19大流行的负面影响et to a great extent due to the decline in these surgeries across the globe. A study titled "The effect of the COVID-19 pandemic on revision total hip and knee arthroplasty at a large academic hospital network" reported in November 2021, discovered that there was a 6.80% reduction in revision total hip arthroplasty due to the uncertainty of COVID-19 infections, which significantly affected the market. Additionally, fewer surgeries were performed for hip replacements as a result of COVID-19 infections, which negatively impacted the market. However, due to the regained stability post-pandemic, the market is anticipated to witness growth during the research period.

Product Insights

市场分为全髋,部分femoral head, hip resurfacing, and revision hip based on the types of products. The total hip replacement implants segment continued to hold the highest market share of 37.5% in 2022 due to the growing number of total hip replacement surgeries across the globe. Since total hip replacement is the most frequent type of hip replacement surgery, the demand for total hip replacement implants is also more. For instance, the Agency for Healthcare Research and Quality estimates that more than 450,000 total hip replacements are carried out annually in the U.S.

On the other hand, the revision hip replacement implants segment is expected to experience the fastest CAGR of 6.5% over the forecast period due to favorable reimbursement policies. For instance, Johnson & Johnson launched their "India-centric" payment program in November 2018, ensuring complete patient coverage for revision surgery within 15 years of the first hip replacement operation.

Material Insights

Based on material, the market is classified into metal-on-metal, metal-on-polyethylene, ceramic-on-polyethylene, ceramic-on-metal, and ceramic-on-ceramic. In 2022, the metal-on-polyethylene segment accounted for the largest market share of 30.8% since metal-on-polyethylene is among the most affordable implant materials. The other advantages of this material include fewer complications and fewer wear particles. Additionally, the industry is experiencing considerable expansion potential due to ongoing breakthroughs in metal-on-polyethylene mixture materials.

Metal-on-polyethylene implants are widely accessible and have a track record of clinical success. Thus, total hip arthroplasty treatments frequently use metal-on-polyethylene hip replacement implants due to their dependability and resistance to wear. However, concerns arising about metal toxicity as well as the possibility of implant corrosion and failure resulted in higher scrutiny of metal-on-polyethylene implants during forecast years.

On the other hand, the ceramic-on-polyethylene segment is anticipated to experience the highest CAGR of 6.9% during the forecast period due to its low wear rate and reduced complications. Ceramic-on-polyethylene hip replacement implants, in comparison to metal-on-polyethylene ones, offer superior wear resistance and are less likely to cause issues, such as metal toxicity and implant corrosion; hence they are anticipated to gain popularity over the forecast period. Some major players in this segment are DePuy Synthes Orthopedics, Stryker, Biomet, and Corin Group.

End-use Insights

The global hip replacement implants end-use segment is categorized into orthopedic clinics, hospitals & surgery centers, and other segments. The hospitals and surgery centers segment held the highest market share of 69.3% in 2022. The segment’s growth is driven by a rise in hip implant surgeries performed in these facilities. These facilities have the most up-to-date technology and qualified medical staff, further accelerating segment growth. Additionally, partnerships between hospitals and key players to develop cutting-edge surgical techniques are encouraging segment growth.

The orthopedic clinics segment is expected to experience the highest CAGR of 6.9% over the forecast period due to the growing number of orthopedic surgeons and outpatient replacement surgeries. The availability of qualified surgeons and the development of an advanced infrastructure can also be associated with this growth. Another significant growth driver is the rise in the number of orthopedic clinics.

Regional Insight

North America dominated the market in 2022 with a revenue share of 45.6%, owing to the rising prevalence of osteoarthritis and the increase in hip replacement surgeries in North America. For instance, according to arthritis data 2022 released in January 2022 by the SingleCare team, more than 32.5 million individuals in the U.S. suffered from osteoarthritis in 2020, and more than 62% were female. Thus, the demand for hip replacement and the need for hip replacement implants will rise during the forecasted period due to a rising incidence of osteoarthritis in the U.S. Moreover, increased R&D activity for advancements in hip replacement surgeries and product approvals contribute to market growth. For instance, in May 2022, The FDA accelerated access to cutting-edge technologies that could enhance hip replacement procedures by designating JointMedica's Polymotion hip resurfacing system as a Breakthrough Device.

Asia Pacific is expected to witness lucrative growth with a CAGR of 9.9% over the forecast period. Growing elderly populations, with a higher chance of developing osteoporosis, osteoarthritis, and bone injuries, as well as a rise in the prevalence of obesity, are all expected to contribute to the regional market growth over the forecast period. In addition, rapidly growing healthcare facilities owing to the expandingmedical tourismsector are driving market growth in the region.

Key Companies & Market Share Insights

Key players are involved in several strategic initiatives to strengthen their market position, including mergers and acquisitions, partnerships, collaborations, and developing and introducing cutting-edge products. For instance, in August 2022, Exactech announced the successful completion of the first total hip arthroplasty procedures using the Spartan Stem and Logical Cup System and the commercial launch of a novel total hip arthroplasty system.

Similarly, in January 2023, under an FDA-approved Investigational Device Exemption (IDE), Hip Innovation Technology, LLC (HIT) announced the first HIT Reverse Hip Replacement System (Reverse HRS) implantation in the U.S. The IDE study aims to evaluate the safety and efficacy of HIT Reverse HRS in Primary Total Hip Arthroplasty (THA). Thus, the growing innovations and product launches are expected to boost the demand for hip replacement implants over the forecast period.

Furthermore, several key players are acquiring advanced technologies to expand their product lines and strengthen their market position. For instance, in March 2022, DePuy Synthes Acquired CUPTIMIZE Hip-Spine Analysis, enabling technology to aid surgeons in better understanding, measuring, and addressing pelvic tilt. This technology will be used with DePuy Synthes hip implants to provide a comprehensive procedural approach to improve patient outcomes.

Additionally, adding advanced technologies in preliminary preparation and intra-operative execution that provide effective, real-time data to personalize hip replacement surgeries is expected to boost demand for hip replacement implants throughout the forecast period. Some prominent players in the global hip replacement implants market include:

• Zimmer Biomet

• Johnson & Johnson

• Stryker Corporation

• Smith & Nephew plc

• MicroPort Scientific Corporation

• Exactech, Inc.

• OMNIlife Science, Inc.

• B. Braun Melsungen AG

• DJO Global, Inc.

• Aesculap Implant Systems, LLC

• ConMed Corporation

Hip Replacement Implants MarketReport Scope

Report Attribute	Details
Market size value in 2023	USD 5.7 billion
Revenue forecast in 2030	USD 8.7 billion
Growth Rate	CAGR of 6.2% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 - 2021
Forecast period	2023 - 2030
Report updated	July 2023
Quantitative units	Revenue in USD billion and CAGR from 2023 to 2030
Report Coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segment Covered	Product, material, end-use, region
Regional scope	North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope	U.S.; Canada; UK; Germany; France; Italy; Spain; Sweden; Denmark; Norway; China; Japan; India; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled	Zimmer Biomet; Johnson & Johnson; Stryker Corporation; Smith & Nephew plc; MicroPort Scientific Corporation; Exactech, Inc.; OMNIlife Science, Inc.; B. Braun Melsungen AG; DJO Global, Inc.; Aesculap Implant Systems, LLC; ConMed Corporation
Customization scope	Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope
革命制度党cing and purchase options	Avail customized purchase options to meet your exact research needs.Explore purchase options

Global Hip Replacements Implants Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research, Inc. has segmented the global hip replacement implants market report based on product, material, end-use, and region:

• Product Outlook (Revenue, USD Billion, 2018 - 2030)

  • Total Hip

  • Partial Femoral Head

  • Hip Resurfacing

  • Revision Hip

• Material Outlook (Revenue, USD Billion, 2018 - 2030)

  • Metal-on-Metal

  • Metal-on-Polyethylene

  • Ceramic-on-Polyethylene

  • Ceramic-on-Metal

  • Ceramic-on-Ceramic

• End-use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Orthopedic Clinics

  • Hospitals & Surgery Centers

  • Others

• Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait